Trial Profile
Bridging with rivaroxaban in patients with chronic use of vitamin K antagonists
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 13 Sep 2011
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Enoxaparin sodium
- Indications Thromboembolism
- Focus Therapeutic Use
- 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
- 31 Aug 2011 New trial record